For the active substances 2,5-dichlorobenzoic acid methylester, acetic acid, aluminium phosphide, ethylene, iron sulphate, magnesium phosphide, metamitron and sulcotrione, the Authority, in consultation with the Member States, may still request additional information from the applicants pursuant to Article 13(3a) of Implementing Regulation (EU) No 844/2012, if it considers this necessary to assess the endocrine disrupting properties of those active substances. The extension periods proposed for those active substances do not include any additional time that might be necessary to provide and evaluate that information.
Recital 40, Regulation (EU) 2026/2348
In force
- celex=32012R0844